Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 9, 2013 - Issue 6
Submit an article Journal homepage
708
Views
14
CrossRef citations to date
0
Altmetric
Commentary

NGcGM3/VSSP vaccine as treatment for melanoma patients

Kirenia Pérez Clinical Trials Division; Center of Molecular Immunology; Havana, CubaCorrespondence[email protected]
,
Marta Osorio Clinical Trials Unit; National Institute of Oncology and Radiobiology; Havana, Cuba
,
Julio Hernández Oncology Division; “Dr. Celestino Hernández Robau” Hospital; Villa Clara, Cuba
,
Adriana Carr Immunobiology Division; Center of Molecular Immunology; Havana, Cuba
&
Luis Enrique Fernández Immunobiology Division; Center of Molecular Immunology; Havana, Cuba
Pages 1237-1240 | Received 13 Feb 2013, Accepted 26 Feb 2013, Published online: 26 Feb 2013

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mayrel Labrada, Isabel Pablos, Francesca Prete, Giselle Hevia, Marilyn Clavell, Federica Benvenuti & Luis E Fernández. (2014) Induction of leukocyte infiltration at metastatic site mediates the protective effect of NGcGM3-based vaccine. Human Vaccines & Immunotherapeutics 10:8, pages 2312-2320.
Read now

Articles from other publishers (13)

Jing Wang, Lucy K. Shewell, Christopher J. Day & Michael P. Jennings. (2023) N-glycolylneuraminic acid as a carbohydrate cancer biomarker. Translational Oncology 31, pages 101643.
Crossref
Mina Hosseini, Simin Seyedpour, Behzad Khodaei, Amir-Hossein Loghman, Nasrin Seyedpour, Mohammad-Hossein Yazdi & Nima Rezaei. (2023) Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review. Vaccines 11:1, pages 146.
Crossref
Elisabetta Cribioli, Greta Maria Paola Giordano Attianese, George Coukos & Melita Irving. (2022) CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissues. Frontiers in Immunology 13.
Crossref
Ya-Jia Xie, Min Huang, Dan Li, Jin-Cai Hou, Hai-Hai Liang, Ali Adnan Nasim, Ju-Min Huang, Chun Xie, Elaine Lai-Han Leung & Xing-Xing Fan. (2022) Bacteria-based nanodrug for anticancer therapy. Pharmacological Research 182, pages 106282.
Crossref
Nora Berois, Alvaro Pittini & Eduardo Osinaga. (2022) Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives. Cancers 14:3, pages 645.
Crossref
Lorry Carrié, Mathieu Virazels, Carine Dufau, Anne Montfort, Thierry Levade, Bruno Ségui & Nathalie Andrieu-Abadie. (2020) New Insights into the Role of Sphingolipid Metabolism in Melanoma. Cells 9:9, pages 1967.
Crossref
Virgil Schijns, Alberto Fernández‐Tejada, Žarko Barjaktarović, Ilias Bouzalas, Jens Brimnes, Sergey Chernysh, Sveinbjorn Gizurarson, Ihsan Gursel, Žiga Jakopin, Maria Lawrenz, Cristina Nativi, Stephane Paul, Gabriel Kristian Pedersen, Camillo Rosano, Ane Ruiz‐de‐Angulo, Bram Slütter, Aneesh Thakur, Dennis Christensen & Ed C. Lavelle. (2020) Modulation of immune responses using adjuvants to facilitate therapeutic vaccination. Immunological Reviews 296:1, pages 169-190.
Crossref
Changping Zheng, Marco Terreni, Matthieu Sollogoub & Yongmin Zhang. (2019) Ganglioside GM3 and Its Role in Cancer. Current Medicinal Chemistry 26:16, pages 2933-2947.
Crossref
Fatemeh Farjadian, Mohsen Moghoofei, Soroush Mirkiani, Amir Ghasemi, Navid Rabiee, Shima Hadifar, Ali Beyzavi, Mahdi Karimi & Michael R. Hamblin. (2018) Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: Set the bugs to work?. Biotechnology Advances 36:4, pages 968-985.
Crossref
Addys González Palomo, Armando López Medinilla, Valeria Segatori, María del Carmen Barroso, Rances Blanco, Mariano R. Gabri, Adriana Carr Pérez & Kalet León Monzón. (2018) Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3. Oncotarget 9:35, pages 24069-24080.
Crossref
Mayrel Labrada, Denise Dorvignit, Giselle Hevia, Nely Rodríguez-Zhurbenko, Ana M. Hernández, Ana M. Vázquez & Luis E. Fernández. (2018) GM3(Neu5Gc) ganglioside: an evolution fixed neoantigen for cancer immunotherapy. Seminars in Oncology 45:1-2, pages 41-51.
Crossref
Rancés Blanco, Damián Blanco, Yisel Quintana, Xiomara Escobar, Charles E. Rengifo, Marta Osorio, Zailí Gutiérrez, Janet Lamadrid, Mercedes Cedeño, Milagros Frómeta, Adriana Carr & Enrique Rengifo. (2013) Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis. Pathology Research International 2013, pages 1-12.
Crossref
Ana Victoria Casadesús, Yuniel Fernández-Marrero, Marilyn Clavell, José Alberto Gómez, Tays Hernández, Ernesto Moreno & Alejandro López-Requena. (2013) A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells. Glycoconjugate Journal 30:7, pages 687-699.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.